Companies › BCAB
BIOATLA INC (BCAB)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001826892 · EDGAR filings · Updated 2026-07-16
BIOATLA INC (BCAB) has 34 institutional managers reporting positions valued at $2.47M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-16 — Current report (8-K) filed
- 2026-06-05 — Insider transaction reported (Form 4)
- 2026-06-05 — Insider transaction reported (Form 4)
- 2026-06-05 — Insider transaction reported (Form 4)
- 2026-06-03 — ARS filed
- 2026-06-03 — DEFA14A filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, BIOATLA INC has 34 institutional holders.
Insider activity
Insiders reported 25 transactions (0 buys, 0 sells) across 10 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
SERINA THERAPEUTICS INC (SER) · ONCOLYTICS BIOTECH INC COM NEW (ONCY) · Bolt Biotherapeutics Inc (BOLT) · CEL SCI Corp (CVM) · LONGEVERON INC (LGVN) · MIRA PHARMACEUTICALS INC COM (MIRA)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.